CD160 and plasma cell myeloma: However, CD160 and TNFRSF14 are highly expressed in a variety of tumors (e.g. chronic lymphocytic leukemia and multiple myeloma) and promote tumor evasion of immune surveillance by regulating NK and T cell activity (48–52).